Discontinued — last reported Q3 '25
Pultegroup Equity Method Investments increased by 0.5% to $168.14M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 23.8%, from $220.79M to $168.14M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 36.3% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $44.80M | $64.28M | $98.16M | $106.06M | $150.50M | $158.09M | $146.76M | $144.66M | $151.30M | $162.29M | $166.91M | $204.12M | $210.25M | $213.02M | $215.42M | $220.79M | $181.80M | $179.19M | $167.34M | $168.14M |
| QoQ Change | — | +43.5% | +52.7% | +8.1% | +41.9% | +5.0% | -7.2% | -1.4% | +4.6% | +7.3% | +2.9% | +22.3% | +3.0% | +1.3% | +1.1% | +2.5% | -17.7% | -1.4% | -6.6% | +0.5% |
| YoY Change | — | — | — | — | +235.9% | +145.9% | +49.5% | +36.4% | +0.5% | +2.7% | +13.7% | +41.1% | +39.0% | +31.3% | +29.1% | +8.2% | -13.5% | -15.9% | -22.3% | -23.8% |